Intracellular protein kinase CK2 inhibition by ferulic acid-based trimodal nanodevice
- 1 December 2020
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 165, 701-712
Abstract
No abstract availableKeywords
Funding Information
- Università degli Studi di Padova
- Fondazione per la Ricerca sulla Fibrosi Cistica
This publication has 54 references indexed in Scilit:
- Detection of Phospho-Sites Generated by Protein Kinase CK2 in CFTR: Mechanistic Aspects of Thr1471 PhosphorylationPLOS ONE, 2013
- Charge binding of rhodamine derivative to OH− stabilized nanomaghemite: Universal nanocarrier for construction of magnetofluorescent biosensorsActa Biomaterialia, 2012
- Nanosuspension: An approach to enhance solubility of drugsJournal of Advanced Pharmaceutical Technology & Research, 2011
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJournal of Controlled Release, 2010
- Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future ProspectsBioconjugate Chemistry, 2010
- Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-β fibrils detection and removal by a magnetic fieldBiochemical and Biophysical Research Communications, 2009
- Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2Biochemical Journal, 2009
- In Vivo Magnetic Resonance Imaging of Single‐Walled Carbon Nanohorns by Labeling with Magnetite NanoparticlesAdvanced Materials, 2006
- Techniques: New approaches to the delivery of biopharmaceuticalsTrends in Pharmacological Sciences, 2004
- The Protein Data BankNucleic Acids Research, 2000